Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 16, 2017

View Archived Issues

TREOS Bio raises funds to support clinical trial of colorectal cancer vaccine

Aequus Pharmaceuticals completes dosing in POC trial of AQS-1301

Allergan to acquire ZELTIQ

Viking Therapeutics reaches funding agreement for clinical development of VK-2809

Consortium of private investors acquires NexImmune

Surrozen closes series A financing

X-Chem, Janssen expand inflammatory disease collaboration

Insys Therapeutics provides cannabidiol oral solution for compassionate use studies

Boehringer Ingelheim and Weill Cornell Medicine enter COPD collaboration

FDA approves Siliq for plaque psoriasis

Phase III data show non-inferiority of doravirine and darunavir/ritonavir

Parsabiv launched in Japan

NCI grant supports breast cancer ADC research at Scripps Research Institute

Promising phase III results of UX-003 in patients with MPS VII

Clinical data reported for Fabry's disease candidate lucerastat

Chong Kun Dang Holdings divulges novel HDAC6 inhibitors

Hetero Research Foundation patents antiviral agents

Nanchang Helioeast identifies novel JAK inhibitors

ALK seeks European approval for ragweed sublingual allergy immunotherapy

Laboratorio Farmaceutico CT Srl patents ROS production inhibitors

Taiho Pharmaceutical discovers JAK3 inhibitors

Vedanta Biosciences collaborates with Stanford University and Leiden University

Roche discloses new mGlu4 receptor positive allosteric modulators

Amunix Operating enters R&D collaboration with Genentech

Tapimmune's phase II study of TPIV-200 in TNBC cleared to continue

Cytori Therapeutics completes acquisition of Azaya Therapeutics

Daiichi Sankyo conducts Japanese phase I trial of DS-1001b in IDH1 mutated gliomas

Daiichi Sankyo's DS-3032b receives U.S. orphan designation for liposarcoma

New mouse model of Staphylococcus aureus vascular graft infection developed

FDA designates Nuedexta an orphan drug for amyotrophic lateral sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...